Proving ROI for digital endpoints
The costs associated with clinical trials are a major bottleneck to drug development and affordability.
Newsletters and Deep Dive digital magazine
The costs associated with clinical trials are a major bottleneck to drug development and affordability.
At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants.
Pilar de la Rocha Mur is Head of Clinical Operations EMEA (Europe, Middle East, and Africa) at BeiGene.
For more than 15 years, shortages of critical drugs — from oncology treatments to emergency room and surgical suite essentials — have burdened healthcare systems and compromised patient car
Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.
Editor's Picks
Newsletters and Deep Dive
digital magazine